Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target

Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target

Transitional cell carcinoma (TCC) is the most common malignant tumor of the canine urinary tract and tends to have a poor prognosis due to its invasive potential. Recent studies have reported that up to 80% of canine urothelial carcinoma has the BRAF V595E mutation, which is homologous to the human...

Full description

Bibliographic Details
Main Authors: Hyojik Jung, Kieun Bae, Ja Young Lee, Jung-Hyun Kim, Hyun-Jung Han, Hun-Young Yoon, Kyong-Ah Yoon
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
dog
transitional cell carcinoma
canine BRAF V595E
cancer cell line
metastatic lymph node
Online Access:https://www.mdpi.com/1422-0067/22/17/9151

Similar Items

Similar Items